Sign Up Today and Learn More About Ensoma Stock
Invest in or calculate the value of your shares in Ensoma or other pre-IPO companies through EquityZen's platform.
Ensoma Stock (ENSO)
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
About Ensoma Stock
Founded
2019
Headquarters
Boston, MA, US
Industries
Blockchain and Crypto, Internet Services, Health Care
Ensoma Press Mentions
Stay in the know about the latest news on Ensoma
Ensoma Announces First Patient Dosed in Phase 1/2 Clinical Trial of EN-374 for Treatment of X-CGD
businesswire • Dec 01, 2025
Financings for Sept. 23, 2025
bioworld • Sep 24, 2025
Ensoma: $53 Million Secured To Advance Stem Cell Therapies And Global Clinical Impact
pulse2 • Sep 23, 2025
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline
biospace • Sep 23, 2025
Charlie Kirk, Jimmy Kimmel, and why CEOs are appeasing Trump
bostonglobe • Sep 23, 2025
Ensoma Management
Leadership team at Ensoma
Board of Directors
Kouki Harasaki
Chief Operating Officer
Min Wang
Join now and verify your accreditation status to gain access to:
- Ensoma Current Valuation
- Ensoma Stock Price
- Ensoma Management
- Available deals in Ensoma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ensoma Cap Table and Funding History by Share Class and Liquidity Preferences
- Ensoma Revenue and Financials
- Ensoma Highlights
- Ensoma Business Model
- Ensoma Risk Factors
- Ensoma Research Report from SACRA Research
Trading Ensoma Stock
How to invest in Ensoma stock?
Accredited investors can buy pre-IPO stock in companies like Ensoma through EquityZen funds. These investments are made available by existing Ensoma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ensoma stock?
Shareholders can sell their Ensoma stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 50K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
